Description

Presented by Medela LLC

Negative Pressure Wound Therapy (NPWT) has become a cornerstone treatment for complex and hard to heal wounds and its distinct mechanisms of action (MOAs) extensively researched. However, there has been little investigation into the fundamental requirements necessary in an NPWT system to effectively deliver these mechanisms and maximize the therapy’s clinical benefits, as not all devices are the same. In this presentation we will:

• Review the NPWT mechanisms of action.
• Discuss the fundamental requirements of an NPWT system and their role in promoting effective delivery of NPWT
• Discuss the results of a recent publication comparing the ability of System A (Invia® Liberty™ NPWT System, Medela AG) and System B (V.A.C.ULTA™ Therapy System, 3M+KCI) to deliver set levels of NPWT to the wound bed and simultaneously manage volumes of simulated wound fluid.
• Review case study data demonstrating improved patient outcomes using both the Invia® Liberty™ and Invia Motion® NPWT Systems.